Not applicableStudy completedNCT01171417
What this trial is testing
A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer
Who this might be right for
PostmenopauseBreast Cancer
AstraZeneca 570